Angiogenesis inhibitors: motivators of metastasis?
Patricia S Steeg
The author is in the Women's Cancers Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA. steegp@mail.nih.gov
Angiogenesis inhibitors have shown promise in hindering blood supply and holding tumors in check. But it now seems that such inhibitors, by depriving tumors of oxygen, could have an unintended effect: promotion of metastasis.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
